EP2371856
Setbeind breyting á FVIII
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.11.2005EP published:
18.5.2022EP application number:
11153297.4
EP translation filed:
18.7.2022Grant published:
15.8.2022EPO information:
European Patent Register
Max expiry date:
13.11.2025Expiry date:
13.11.2025
Title in English:
Site-directed modification of FVIIILanguage of the patent:
English
Timeline
Today
14.11.2005EP application
18.5.2022EP Publication
18.7.2022Translation submitted
15.8.2022Registration published
13.11.2025Expires
Owner
Name:
Bayer HealthCare LLCAddress:
100 Bayer Boulevard, Whippany, NJ 07981-0915, US
Inventor
Name:
Pan, Clark Q.Address:
Sudbury, MA 01776, US
Name:
Murphy, John E.Address:
Berkeley, California 94707, US
Name:
Mei, BaisongAddress:
Waban, MA 02468, US
Name:
Strauss, Jonathan S.Address:
Cambridge, MA 02139, US
Name:
Tjandra, HendriAddress:
Union City, California 94587-5503, US
Name:
Chen, JianminAddress:
Concord, California 94518, US
Name:
Barnett, ThomasAddress:
Willsborough, NJ 08844, US
Name:
Tang, JiangAddress:
Hercules, California 94547, US
Name:
Wamg, DeqianAddress:
Concord, California 94521, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
627277 PDate:
12.11.2004Country:
US
Classification
Categories:
A61K 47/48, A61K 38/00, C07K 14/755
Annual fees
Number
Paid
Expires
Payer
Number: 18
Paid: 27.10.2022
Expires: 13.11.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 7.11.2023
Expires: 13.11.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 23.10.2024
Expires: 13.11.2025
Payer: Árnason Faktor ehf.